Abstract
Treatment of stable angina pectoris (AP) has to be complex. It consists of necessary preventive measures, pharmacological therapy and revascularization procedures, either catheterization or surgical.
Pharmacological therapy and invasive revascularization procedures are not competitive, but they are complementary. The article brings an overview of pharmacological treatment of stable AP.
In all patients secondary prevention measures has to be apllied, non-pharmacological as well as pharmacological ones. It is possible to divide formally pharmacological treatment of stable AP into treatment influencing prognosis (antiplatelet drugs, statins, RAAS inhibitors and betablockers) and treatment influencing symptoms (betablockers, ivabradine, calcium channel blockers, long-acting nitrates and metabolically acting drugs).
Betablockers as the only drugs improving both, the prognosis and symptoms, therefore they are the antianginal drugs of the first choice.